<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        124-276-15
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2015
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        BOOSTRIX VACCINE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DIPHTHERIA TOXOID,TETANUS TOXOID,Haemagglutinin,PERTACTIN,ACELLULAR PERTUSSIS
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2,20,8,2.5,8
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suspension for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        0
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        18
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        63.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXO SMITHKLINE BIOLOGICALS " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXO SMITHKLINE BIOLOGICALS 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J07CA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Boostrix is a vaccine used as a booster dose in children from 4 years onwards, teenagers and adults to prevent three diseases: diphtheria, tetanus (lockjaw) and pertussis (whooping cough). The vaccine works by causing the body to produce its own protection (antibodies) against these diseases.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Diphtheria:</strong> Diphtheria mainly affects the airways and sometimes the skin. Generally the airways become inflamed (swollen) causing severe breathing difficulties and sometimes suffocation. The bacteria also release a toxin (poison), which can cause nerve damage, heart problems, and even death.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Tetanus</strong> (Lockjaw): Tetanus bacteria enter the body through cuts, scratches or wounds in the skin. Wounds that are especially prone to infection are burns, fractures, deep wounds or wounds contaminated with soil, dust, horse manure/dung or wood splinters. The bacteria release a toxin (poison), which can cause muscle stiffness, painful muscle spasms, fits and even death. The muscle spasms can be strong enough to cause bone fractures of the spine.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Pertussis</strong> (Whooping cough): Pertussis is a highly infectious illness. The disease affects the airways causing severe spells of coughing that may interfere with normal breathing. The coughing is often accompanied by a &ldquo;whooping&rdquo; sound, hence the common name &ldquo;whooping cough&rdquo;. The cough may last for 1-2 months or longer. Pertussis can also cause ear infections, bronchitis which may last a long time, pneumonia, fits, brain damage and even death.</p><p>&nbsp;</p><p>None of the ingredients in the vaccine can cause diphtheria, tetanus or whooping cough.</p><p>&nbsp;</p><p>The use of Boostrix during pregnancy will help to protect your baby from whooping cough in the first few months of life before he/she receives the primary immunisation.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Boostrix should not be given:</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have previously had any allergic reaction to Boostrix, or any of the other ingredients contained in this vaccine (listed in section 6) or formaldehyde. Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have previously had an allergic reaction to any vaccine against diphtheria, tetanus or whooping cough diseases.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child experienced problems of the nervous system (encephalopathy) within 7 days after previous vaccination with a vaccine against pertussis (whooping cough) disease.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have a severe infection with a high temperature (over 38&deg;C). A minor infection should not be a problem, but talk to your doctor first.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child experienced a temporary reduction in blood platelets (which increases risk of bleeding or bruising) or problems with the brain or nerves after previous vaccination with a vaccine against diphtheria and/or tetanus.</p><p><strong>&nbsp;</strong></p><p><strong>Warnings and precautions</strong></p><p><strong>&nbsp;</strong></p><p><strong>Talk to your doctor or pharmacist before you or your child are given Boostrix:</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if after previously having Boostrix or another vaccine against pertussis (whooping cough) disease, you or your child had any problems, especially:</p><p>-&nbsp;&nbsp;&nbsp; A high temperature (over 40&deg;C) within 48 hours of vaccination</p><p>-&nbsp;&nbsp;&nbsp; A collapse or shock-like state within 48 hours of vaccination</p><p>-&nbsp;&nbsp;&nbsp; Persistent crying lasting 3 hours or more within 48 hours of vaccination</p><p>-&nbsp;&nbsp;&nbsp; Seizures/fits with or without a high temperature within 3 days of vaccination</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child is suffering from an undiagnosed or progressive disease of the brain or uncontrolled epilepsy. After control of the disease the vaccine should be administered.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have a bleeding problem or bruise easily</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have a tendency to seizures/fits due to a fever, or if there is a family history of this</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have long standing immune system problems due to any reason (including HIV infection). You or your child may still be given Boostrix but the protection against infections after having the vaccine may not be as good as in children or adults with good immunity to infections.</p><p>Fainting can occur (mostly in adolescents) following, or even before, any needle injection.&nbsp; Therefore tell the doctor or nurse if you or your child fainted with a previous injection.</p><p>&nbsp;</p><p>As with all vaccines Boostrix may not completely protect all people who are vaccinated.</p><p>&nbsp;</p><p><strong>Other medicines and Boostrix</strong></p><p><strong>&nbsp;</strong></p><p>Tell your doctor or pharmacist if you or your child are taking, have recently taken, or might take<strong><em> </em></strong>any other medicines or have recently received any other vaccine.</p><p>&nbsp;</p><p>Boostrix can be given at the same time as some other vaccines. A different injection site will be used for each type of vaccine.</p><p>&nbsp;</p><p>Boostrix may not work as well if you or your child are taking medicines that reduce the effectiveness of your/their immune system to fight infection.</p><p>&nbsp;</p><p><strong>Pregnancy and breastfeeding</strong></p><p><strong>&nbsp;</strong></p><p>If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before you are given this vaccine.</p><p>It is not known if Boostrix passes into breast milk. Your doctor will discuss with you the possible risks and benefits of having Boostrix during breastfeeding.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span lang=EN-GB style='mso-bidi-font-size:
11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
mso-no-proof:yes'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_87eadd13-c578-43bb-9c18-9030dfc3e1f3 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></b><![endif]--><strong>&nbsp;</strong><!--[if supportFields]><b
style='mso-bidi-font-weight:normal'><span lang=EN-GB style='mso-bidi-font-size:
11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
mso-no-proof:yes'><span style='mso-element:field-end'></span></span></b><![endif]--></p><p><strong>&nbsp;</strong></p><p>Boostrix is unlikely to produce an effect on the ability to drive and use machines.<!--[if supportFields]><span
style='mso-bidi-font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi;mso-ansi-language:EN-US'><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_e4985b08-b297-4c42-b622-97dab40843a7
\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='mso-bidi-font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi;mso-ansi-language:EN-US'><span style='mso-element:
field-end'></span></span><![endif]--></p><p>&nbsp;</p><p><strong>Boostrix contains sodium</strong></p><p>&nbsp;</p><p>This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if !supportLists]--></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Boostrix will be given as an injection into the muscle.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The vaccine should never be given into blood vessels.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You or your child will receive a single injection of Boostrix.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will verify if you or your child have previously received vaccines against diphtheria, tetanus and/or pertussis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Boostrix may be used in case of a suspected infection with tetanus, although additional provisions, i.e. elaborate wound dressing and/or application of Tetanus-anti-Toxin will be taken as well to reduce the risk of manifestation of the disease.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will give you advice on repeat vaccination.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this vaccine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>As with all injectable vaccines severe allergic reactions (anaphylactic and anaphylactoid reactions) may occur very rarely (with up to 1 in 10,000 doses of the vaccine). These can be recognised by:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rashes that may be itchy or blistering,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Swelling of the eyes and face</strong>,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Difficulty in breathing or swallowing</strong>,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A sudden drop in blood pressure and <strong>loss of consciousness. </strong></p><p>Such reactions may occur before leaving the doctor&rsquo;s surgery. However, <strong>if you or your child get any of these symptoms you should contact a doctor immediately.</strong></p><p>&nbsp;</p><p><em>&nbsp;</em></p><p><em>Side effects that occurred during clinical trials in children from the age of 4 to 8 </em>years</p><p>&nbsp;</p><p><strong>Very common </strong>(these may occur with more than 1 in 10 doses of the vaccine): pain, redness and swelling at the injection site, irritability, sleepiness, tiredness.</p><p><u>&nbsp;</u></p><p><strong>Common </strong>(these may occur with up to 1 in 10 doses of the vaccine): loss of appetite, headache,</p><p>fever equal to or greater than 37.5&deg;C (including fever greater than 39&deg;C), large swelling of the vaccinated limb, vomiting and diarrhoea.</p><p><u>&nbsp;</u></p><p><strong>Uncommon </strong>(these may occur with up to 1 in 100 doses of the vaccine): upper respiratory tract infection, disturbances in attention, discharge with itching of the eyes and crusty eyelids (conjunctivitis), skin rash, hard lump where the injection was given, pain.</p><p><u>&nbsp;</u></p><p><em>Side effects that occurred during clinical trials in adults, teenagers and children from the age of 10 years onwards</em></p><p>&nbsp;</p><p><strong>Very common </strong>(these may occur with more than 1 in 10 doses of the vaccine): pain, redness and swelling at the injection site, headache, tiredness, generally feeling unwell.</p><p><u>&nbsp;</u></p><p><strong>Common </strong>(these may occur with up to 1 in 10 doses of the vaccine): fever equal to or greater than 37.5&deg;C, dizziness, nausea, hard lump and abscess at the injection site.</p><p><u>&nbsp;</u></p><p><strong>Uncommon </strong>(these may occur with up to 1 in 100 doses of the vaccine): fever greater than 39&deg;C,</p><p>pain, joint and muscle stiffness, vomiting, diarrhoea, joint stiffness, joint pain, muscle ache, itching, excessive sweating (hyperhidrosis), skin rash, swollen glands in the neck, armpit or groin (lymphadenopathy), sore throat and discomfort when swallowing (pharyngitis), upper respiratory tract infection, cough, fainting (syncope), flu-like symptoms, such as fever, sore throat, runny nose, cough and chills.</p><p><em>&nbsp;</em></p><p>The following side effects occurred during routine use of Boostrix and are not specific for any age group: swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing (angioedema), collapse or periods of unconsciousness or lack of awareness, seizures or fits (with or without fever), hives (urticaria), unusual weakness (asthenia).</p><p>&nbsp;</p><p>Following administration of vaccines against tetanus a temporary inflammation of the nerves, causing pain, weakness and paralysis in the extremities and often progressing to the chest and face have been reported very rarely (with up to 1 in 10,000 doses of the vaccine) (Guillain-Barr&eacute; Syndrome).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this vaccine out of the sight and reach of children.</p><p>&nbsp;</p><p>Do not use this vaccine after the expiry date which is stated on the carton and the pre-filled syringe label after EXP. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Store in a refrigerator (2&deg;C &ndash; 8&deg;C).</p><p>Do not freeze. Freezing destroys the vaccine.</p><p>Store in the original package in order to protect from light.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you or your child no longer use.&nbsp; These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Boostrix contains</strong></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substances are:</p><p>Diphtheria toxoid<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not less than 2 International Units (IU) (2.5 Lf)</p><p>Tetanus toxoid<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not less than 20 International Units (IU) (5 Lf)</p><p><em>Bordetella pertussis</em> antigens</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pertussis toxoid<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8 micrograms</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filamentous Haemagglutinin<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8 micrograms</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pertactin<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.5 micrograms</p><p>&nbsp;</p><p><sup>1</sup> adsorbed on aluminium hydroxide, hydrated (Al(OH)<sub>3</sub>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.3 milligrams Al<sup>3+</sup></p><p>and aluminium phosphate (AlPO<sub>4</sub>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.2 milligrams Al<sup>3+</sup></p><p>&nbsp;</p><p>Aluminium hydroxide and aluminium phosphate are included in this vaccine as adjuvants. Adjuvants are substances included in certain vaccines to accelerate, improve and/or prolong the protective effects of the vaccine.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are: sodium chloride and water for injections.</p><p><img alt="" width="400" height="306" src="data:image/png;base64,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" /></p><p><strong>&nbsp;</strong></p><p><u>Disposal</u>:</p><p><strong>&nbsp;</strong></p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Suspension for injection in pre-filled syringe.
Boostrix is a white, slightly milky liquid presented in a pre-filled syringe (0.5 ml). 
Boostrix is available in 1-dose pre-filled syringe with or without separate needles, pack sizes 1 and 10.

Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder:</strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA.</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia.</p><p>*member of GlaxoSmithKline group of companies.</p><p>&nbsp;</p><p><strong>Manufacturer:</strong></p><p>GlaxoSmithKline Biologicals S.A.</p><p>Rue de l&rsquo;Institut 89</p><p>B-1330 Rixensart</p><p>Belgium</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>-GSK - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>Website: https://gskpro.com/en-sa/ &nbsp;</li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul><p>To report any side effect(s):</p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp; Reporting Hotline:19999</p><p>&middot;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p><strong>-GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp; Email: saudi.safety@gsk.com<u>&nbsp; </u></p><p>&middot;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/<u> </u></p><p>&middot;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
Version number: UK Issue 14 draft 1 
Date of issue: 20 July 2023 

Boostrix is a registered trademark of the GlaxoSmithKline group of companies.
	© 2023 GlaxoSmithKline group of companies. All rights reserved
	

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">بوستريكس هو لقاح يُستخدم كجرعة مُعزِّزة للأطفال من عمر 4 سنوات، والمراهقين والبالغين للوقاية من ثلاثة أمراض: الخناق والتيتانوس (الكزاز) والشاهوق (السعال الديكي). يعمل اللقاح عن طريق دفع الجسم إلى إنتاج حمايته الخاصة<br />(المتمثلة في الأجسام المضادة) من هذه الأمراض.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الخناق:</strong> يؤثر الخناق بشكل رئيسي على الشُعب الهوائية، وعلى الجلد أحيانًا. حيث تلتهب (تتورم) الشُعب الهوائية بشكلٍ عام، الأمر الذي يسبب صعوبات حادة في التنفس واختناقًا في بعض الأحيان. وتطلق البكتيريا أيضًا مادة سامة (سمًا) يمكن أن تسبب تلفًا في الأعصاب ومشاكل في القلب وحتى الموت.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>التيتانوس</strong> (الكزاز): تدخل بكتيريا التيتانوس في الجسم من خلال الشقوق أو الخدوش أو الجروح التي تصيب الجلد. والجروح المُعرَّضة بشكل خاص للإصابة بالعدوى هي الجروح المتعلقة بالحروق أو الكسور أو الجروح العميقة أو الجروح التي تعرضت للتلوث بالأتربة أو الغبار أو روث الخيل أو الشظايا الخشبية. وتطلق البكتيريا مادة سامة (سمًا)، وقد تؤدي هذه المادة السامة إلى تصلب العضلات وتشنجات العضلات المؤلمة والنوبات وحتى الوفاة. وقد تكون تشنجات العضلات قوية لدرجة تسبب كسور العظام في العمود الفقري.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الشاهوق</strong> (السعال الديكي): الشاهوق هو مرض شديد العدوى. ويؤثر هذا المرض على الشعب الهوائية، مسببًا نوبات حادة من السعال قد تعوق التنفس بشكل طبيعي. وغالبًا ما يكون السعال مصحوبًا بصوت يشبه &quot;صياح الديك&quot;، ومن هنا جاء الاسم الشائع &quot;السعال الديكي&quot;. وقد يستمر السعال لمدة شهر إلى شهرين أو أكثر. كما يمكن أن يسبب الشاهوق عدوى الأذن والتهاب الشُعب الهوائية، والتي قد تستمر لفترة طويلة، والالتهابات الرئوية والنوبات وتلف الدماغ<br />وحتى الوفاة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا يمكن أن يسبب أي من مكوّنات اللقاح مرض الخناق أو التيتانوس أو السعال الديكي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يساعد استخدام بوستريكس أثناء الحمل على حماية طفلك من السعال الديكي في الأشهر القليلة الأولى بعد الولادة قبل أن يتلقى التطعيم الأول.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم إعطاء بوستريكس في الحالات التالية:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد تعرضت أو تعرض طفلك في السابق لأي تفاعل حساسية للقاح بوستريكس أو أي من المكوِّنات الأخرى للقاح (الواردة بالقسم 6) أو فورمالدهيد. قد تشمل علامات حدوث حساسية ظهور الطفح الجلدي المثير للحكة وضيق التنفس وتورم الوجه أو اللسان.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك أو لدى طفلك حساسية سابقة لأي لقاح لأمراض الخناق أو التيتانوس أو السعال الديكي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد أُصبت أنت أو طفلك بمشاكل في الجهاز العصبي (اعتلال دماغي) خلال 7 أيام بعد تطعيم سابق بلقاح ضد الشاهوق (السعال الديكي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت أنت أو طفلك مصابًا بعدوى شديدة مع ارتفاع في درجة الحرارة (أعلى من 38 درجة مئوية). وليس من المُفترض أن يمثل وجود عدوى بسيطة مشكلةً، ولكن يجب استشارة الطبيب أولاً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد أُصبت أنت أو طفلك بانخفاض مؤقت في الصفائح الدموية (يزيد من خطر النزيف أو الكدمات) أو مشاكل في الدماغ أو الأعصاب بعد تطعيم سابق بلقاح ضد الخناق و/أو التيتانوس.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>يجب استشارة الطبيب أو الصيدلي قبل أن يتم إعطاء بوستريكس لك أو لطفلك:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرضت أنت أو طفلك فيما سبق لأي مشاكل صحية بعد استعمال لقاح بوستريكس أو أي لقاح آخر للشاهوق (السعال الديكي)، خاصةً المشاكل التالية:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; ارتفاع درجة الحرارة (أكثر من 40 درجة مئوية) خلال 48 ساعة من التطعيم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; الهبوط أو التعرض لحالة تشبه الصدمة خلال 48 ساعة من التطعيم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; البكاء المستمر لمدة 3 ساعات أو أكثر خلال 48 ساعة من التطعيم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; التشنجات/النوبات المصحوبة أو غير المصحوبة بارتفاع درجة الحرارة خلال 3 أيام من التطعيم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان طفلك يعاني من مرض دماغي غير مُشخّص أو مترقي أو الصرع الذي لا يمكن التحكم به. يجب إعطاء اللقاح بعد السيطرة على المرض.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أنت أو طفلك من مشكلة متعلقة بالنزيف أو سهولة الإصابة بالكدمات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك استعداد أنت أو طفلك لحدوث التشنجات/النوبات بسبب الحمى، أو إذا كان هناك تاريخ وراثي لهذا الأمر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أنت أو طفلك من مشاكل في جهاز المناعة لفترة طويلة لأي سبب (بما في ذلك عدوى فيروس نقص المناعة البشرية). وقد يتم إعطاؤك أنت أو طفلك بوستريكس على الرغم من ذلك، ولكن الحماية ضد العدوى بعد اللقاح قد لا تكون جيدة بنفس الدرجة كما هي في الأطفال أو البالغين الذين لديهم مناعة جيدة ضد العدوى.</p><p dir="RTL">قد يحدث إغماء (بين المراهقين في معظم الأحيان) بعد أي عملية حقن بإبرة أو حتى قبل الحقن بها. وبالتالي يجب إبلاغ الطبيب أو الممرضة إذا كنت قد أُصبت بالإغماء أو أصيب طفلك بالإغماء عند حقنه في السابق.</p><p dir="RTL">&nbsp;</p><p dir="RTL">وكما هو الحال في جميع اللقاحات، قد لا يحمي بوستريكس بشكل كامل جميع الأشخاص الذين يتم تطعيمهم به.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى وبوستريكس</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أنت أو طفلك حاليًا أو إذا كنت قد تناولت أنت أو طفلك مؤخرًا أية أدوية أخرى أو قد تتناول أنت أو طفلك أية أدوية أخرى أو إذا كنت قد أخذت أنت أو طفلك مؤخرًا أي لقاح آخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن إعطاء بوستريكس في نفس الوقت مع بعض اللقاحات الأخرى. سيتم استخدام موقع حقن مختلف لكل نوع من أنواع اللقاح.</p><p dir="RTL">قد لا يعمل بوستريكس أيضًا إذا كنت تتناول أنت أو طفلك أدوية تقلل من فعالية جهاز المناعة لمكافحة العدوى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">في حالة الحمل أو الرضاعة الطبيعية أو إذا كنتِ تظنين أنكِ حامل أو تخططين للإنجاب، يجب استشارة الطبيب أو الصيدلي قبل أن يتم إعطاؤك هذا اللقاح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ليس من المعروف ما إذا كان بوستريكس ينتقل إلى لبن الأم. سيناقش طبيبِك معكِ المخاطر والفوائد المحتملة لاستعمال بوستريكس أثناء الرضاعة الطبيعية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong><!--[if supportFields]><b style='mso-ansi-font-weight:
normal'><span lang=AR-SA style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
style='mso-element:field-begin'></span> </span></b><span dir=LTR
style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><b
style='mso-ansi-font-weight:normal'><span style='mso-bidi-font-size:11.0pt;
font-family:"Arial",sans-serif'><span dir=RTL></span><span dir=RTL></span> </span></b><span
dir=LTR style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;
mso-bidi-font-weight:bold'>VAULT_ND_5de60e24-7814-4db0-a9d6-7f7543d943bf \*
MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><b
style='mso-ansi-font-weight:normal'><span style='mso-bidi-font-size:11.0pt;
font-family:"Arial",sans-serif'><span dir=RTL></span><span dir=RTL></span> <span
lang=AR-SA><span style='mso-element:field-separator'></span></span></span></b><![endif]--><strong>&nbsp;</strong><!--[if supportFields]><b
style='mso-ansi-font-weight:normal'><span lang=AR-SA style='mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif'><span style='mso-element:field-end'></span></span></b><![endif]--></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">من غير المرجح أن يؤثر بوستريكس على قدرتك على القيادة واستخدام الآلات.<!--[if supportFields]><span lang=AR-SA
style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
style='mso-element:field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
dir=RTL></span><span dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif'>VAULT_ND_c4074a38-8159-40c4-b103-3bae7f8e1dc9
\* MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span dir=RTL></span><span
dir=RTL></span> <span lang=AR-SA><span style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
style='mso-element:field-end'></span></span><![endif]--></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>بوستريكس يحتوي على الصوديوم</strong><!--[if supportFields]><b style='mso-ansi-font-weight:
normal'><span lang=AR-SA style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
style='mso-element:field-begin'></span> </span></b><span dir=LTR
style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-bidi-font-weight:
bold'>DOCVARIABLE</span><span dir=RTL></span><span dir=RTL></span><b
style='mso-ansi-font-weight:normal'><span style='mso-bidi-font-size:11.0pt;
font-family:"Arial",sans-serif'><span dir=RTL></span><span dir=RTL></span> </span></b><span
dir=LTR style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;
mso-bidi-font-weight:bold'>VAULT_ND_274c9b97-73e0-4767-a000-8c63fb5000b3 \*
MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><b
style='mso-ansi-font-weight:normal'><span style='mso-bidi-font-size:11.0pt;
font-family:"Arial",sans-serif'><span dir=RTL></span><span dir=RTL></span> <span
lang=AR-SA><span style='mso-element:field-separator'></span></span></span></b><![endif]--><strong>&nbsp;</strong><!--[if supportFields]><b
style='mso-ansi-font-weight:normal'><span lang=AR-SA style='mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif'><span style='mso-element:field-end'></span></span></b><![endif]--></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 مليمول صوديوم (23 ملغ) لكل جرعة ، أي انه يعتبر &quot;خالي من الصوديوم&quot;.<!--[if supportFields]><span lang=AR-SA
style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
style='mso-element:field-begin'></span> </span><span dir=LTR style='mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif'>DOCVARIABLE</span><span dir=RTL></span><span
dir=RTL></span><span style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
dir=RTL></span><span dir=RTL></span> </span><span dir=LTR style='mso-bidi-font-size:
11.0pt;font-family:"Arial",sans-serif'>VAULT_ND_5995bc3d-72eb-4f59-b23b-110ef1d520d2
\* MERGEFORMAT</span><span dir=RTL></span><span dir=RTL></span><span
style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span dir=RTL></span><span
dir=RTL></span> <span lang=AR-SA><span style='mso-element:field-separator'></span></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
style='mso-element:field-end'></span></span><![endif]--></p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
style='mso-element:field-end'></span></span><![endif]--></p><p dir="RTL"><!--[if supportFields]><span
lang=AR-SA style='mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif'><span
style='mso-element:field-end'></span></span><![endif]--></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><!--[if !supportLists]--></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحقن بوستريكس في العضل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم إعطاء اللقاح عن طريق الأوعية الدموية مطلقًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يتم حقنك أنت أو طفلك ببوستريكس مرة واحدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيتحقق طبيبك مما إذا كنت قد أخذت أنت أو طفلك من قبل لقاحات ضد الخناق و/أو التيتانوس و/أو الشاهوق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن استخدام بوستريكس في حالة الاشتباه في وجود عدوى بالتيتانوس، على الرغم من أنه يتم إعطاء علاجات أخرى، مثل تضميد الجرح و/أو وضع ترياق التيتانوس أيضًا لتقليل خطر ظهور هذا المرض.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيقدم لك الطبيب المشورة بشأن تكرار التطعيم.</p><p dir="RTL"><strong><u>&nbsp;</u></strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يمكن أن يتسبب هذا اللقاح، مثل جميع الأدوية الأخرى، في حدوث آثار جانبية، لكن ليس بالضرورة أن يصاب بها جميع الأشخاص.</p><p dir="RTL">&nbsp;</p><p dir="RTL">كما هو الحال مع جميع اللقاحات القابلة للحقن، قد تحدث تفاعلات حساسية شديدة (تفاعلات تأقية وتأقانية) بصورة نادرة جدًا (نسبة تصل إلى حالة واحدة بين كل 10000 جرعة من اللقاح). وتتمثل هذه التفاعلات في:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي قد يكون مصحوبًا بحكة أو بثور</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>تورم العينين والوجه</strong>,</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>صعوبة في التنفس أو البلع</strong>,</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مفاجئ في ضغط الدم و<strong>فقدان الوعي</strong>.</p><p dir="RTL">قد تحدث هذه التفاعلات قبل مغادرة عيادة الطبيب. ولكن <strong>إذا أُصبت أنت أو طفلك بأي من هذه الأعراض، يجب عليك الاتصال بطبيب على الفور.</strong></p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>الآثار الجانبية التي حدثت أثناء التجارب السريرية لدى الأطفال الذين تتراوح أعمارهم ما بين 4 إلى 8</em> سنوات</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشائعة جدًا</strong> (قد تصيب أكثر من حالة واحدة بين كل 10 جرعات من اللقاح): ألم واحمرار وتورم في موضع الحقن، سرعة الانفعال، نعاس، إجهاد.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL"><strong>الشائعة</strong> (قد تصيب نسبة تصل إلى حالة واحدة بين كل 10 جرعات من اللقاح): فقدان الشهية، صداع، حمى تكون فيها درجة الحرارة 37,5 درجة مئوية أو أعلى (بما في ذلك الحمى التي تزيد فيها درجة الحرارة عن 39 درجة مئوية)، تورم كبير في الطرف المحقون باللقاح، قيء وإسهال.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL"><strong>غير شائعة</strong> (قد تصيب نسبة تصل إلى حالة واحدة بين كل 100 جرعة من اللقاح): عدوى الجهاز التنفسي العلوي، اضطرابات في الانتباه، إفرازات وحكة في العينين، وجفون قشرية (التهاب الملتحمة)، طفح جلدي، كتلة صلبة في مكان الحقن، ألم.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL"><em>الآثار الجانبية التي حدثت أثناء التجارب السريرية لدى البالغين والمراهقين والأطفال من سن 10 سنوات فما فوق</em></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشائعة جدًا</strong> (قد تصيب أكثر من حالة واحدة بين كل 10 جرعات من اللقاح): ألم واحمرار وتورم في موضع الحقن، صداع، إجهاد، شعور عام بعدم الراحة.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL"><strong>الشائعة</strong> (قد تصيب نسبة تصل إلى حالة واحدة بين كل 10 جرعات من اللقاح): &nbsp;حمى تكون فيها درجة الحرارة درجة مئوية أو أعلى، دوار، غثيان، كتلة صلبة وخُراج في موضع الحقن.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL"><strong>غير شائعة</strong> (قد تصيب نسبة تصل إلى حالة واحدة بين كل 100 جرعة من اللقاح): &nbsp;درجة مئوية، ألم، تيبس المفاصل والعضلات، قيء، إسهال، تيبس المفاصل وآلام المفاصل والعضلات، حكة، فرط التعرُّق (زيادة إفراز العرق) ، طفح جلدي، تورم الغدد في الرقبة أو الإبط أو الفخذ (تضخم العقد اللمفية)، التهاب الحلق وعدم الراحة عند البلع (التهاب البلعوم)، عدوى الجهاز التنفسي العلوي، سعال، إغماء (غشي)، أعراض تشبه أعراض الإنفلونزا، مثل الحمى والتهاب الحلق وسيلان الأنف والسعال والرعشة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">حدثت الآثار الجانبية التالية أثناء الاستخدام الروتيني لبوستريكس ولا تقتصر على فئة عمرية محددة: تورم في الوجه أو الشفتين أو الفم أو اللسان أو الحلق، الأمر الذي قد ينتج عنه صعوبة في البلع أو التنفس (وذمة وعائية)، إغماء أو فترات من فقدان الوعي أو نقص الوعي، تشنجات أو نوبات (مصحوبة أو غير مصحوبة بحمى)، شرى، ضعف غير معتاد (وهن).</p><p dir="RTL">&nbsp;</p><p dir="RTL">بعد إعطاء اللقاحات ضد التيتانوس، تم الإبلاغ عن حالات نادرة جدًا من الالتهاب المؤقت للأعصاب، الذي يسبب حدوث ألم وضعف وشلل في الأطراف، وغالبًا ما يتطور إلى الصدر والوجه (بنسبة تصل إلى حالة واحدة بين كل 10000 جرعة من اللقاح) (متلازمة جيلان باريه).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب حفظ اللقاح بعيدًا عن متناول ومرأى الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم هذا اللقاح بعد تاريخ انتهاء الصلاحية المُدوَّن على العبوة ومُلصق المحقنة المملوءة مسبقًا بعد كلمة &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُحفظ في الثلاجة (بين 2 إلى 8 درجات مئوية).</p><p dir="RTL">يجب عدم تجميده. فالتجميد يتلف اللقاح.</p><p dir="RTL">يُحفظ في العبوة الأصلية لحمايته من الضوء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&rlm;‫لا تتخلص من الأدوية برميها في مياه الصرف أو مع المخلفات المنزلية. استشر الصيدلي بشأن كيفية التخلص من الأدوية التي لم تعد تستخدمها أنت أو طفلك. &rlm;‫فهذه الإجراءات من شأنها المساعدة على حماية البيئة.&rlm;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتويات بوستريكس</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المواد الفعَّالة هي:</p><p dir="RTL">ذوفان الخناق<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يقل عن وحدتين دوليتين (IU) (2.5 Lf)</p><p dir="RTL">ذوفان التيتانوس<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يقل عن 20 وحدة دولية (IU) (5 Lf)</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">مستضدات <em>البورديتيلة الشاهوقية</em></p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ذوفان الشاهوق<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8 ميكروجرام</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫الهيماجلوتينين الخيطي<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8 ميكروجرام</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البيرتاكتين<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,5 ميكروجرام</p><p dir="RTL">&nbsp;</p><p dir="RTL"><sup>1</sup> مُمْتَز في هيدروكسيد الألومنيوم، الرطب (Al(OH)<sub>3</sub>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0,3 مليجرام Al<sup>3+</sup></p><p dir="RTL">وفوسفات الألومنيوم (AlPO<sub>4</sub>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0,2 مليجرام Al<sup>3+</sup></p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي هذا اللقاح على هيدروكسيد الألومنيوم &rlm;‫وفوسفات الألومنيوم كمواد مساعدة. المواد المساعدة هي مواد تتم إضافتها لبعض اللقاحات لتسريع التأثيرات الوقائية للقاح و/أو تحسينها و/أو إطالة مدتها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكوّنات الأخرى هي: كلوريد الصوديوم وماء للحقن.</p><p dir="RTL"><strong><u>&nbsp;</u></strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شكل بوستريكس ومحتويات العبوة</strong></p><p dir="RTL">مُعلّق للحقن في محقنة مملوءة مسبقًا.</p><p dir="RTL">بوستريكس هو سائل أبيض حليبي بعض الشيء يتوفر على شكل محقنة مملوءة مسبقًا (0,5 مل).</p><p dir="RTL">يتوفر بوستريكس في حقنة مملوءة مسبقًا ذات جرعة واحدة مع الإبرمنفصلة أو بدونها، عبوات تحتوى على محقنة واحدة و 10 محقنات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد لا تتوفر جميع أحجام العبوات في السوق</p><p dir="RTL"><em>بوستريكس </em>هو علامة تجارية مسجلة لمجموعة شركات GlaxoSmithKline.</p><p dir="RTL"><strong>حقوق الطبع </strong>&copy;<strong> لعام 2023 محفوظة لمجموعة شركات </strong><strong>GlaxoSmithKline</strong><strong>. كافة الحقوق محفوظة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><img src="data:image/png;base64,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" alt="" width="400" height="247" vspace="0" hspace="0" border="0" style="width:400px;height:247px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL"><u>كيفية التخلص</u><strong><u> </u></strong><u>&nbsp;من اللقاح</u></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يجب التخلص من أي منتج دوائي غير مستخدم أو نفايات وفقًا للشروط المحلية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>-مالك التسويق المعتمد:</strong></p><p dir="RTL">Glaxo Saudi Arabia Ltd.* جدة، المملكة العربية السعودية</p><p dir="RTL">العنوان: ص. ب. 22617 جدة 21416 &ndash; المملكة العربية السعودية.</p><p dir="RTL">*إحدى شركات GlaxoSmithKline.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>-الشركة المصنعة: </strong></p><p dir="RTL">GlaxoSmithKline Biologicals S.A.</p><p dir="RTL">Rue de l&rsquo;Institut 89</p><p dir="RTL">B-1330 Rixensart</p><p dir="RTL">بلجيكا</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإستفسار عن أي معلومات عن هذا المستحضرالدوائي، يُرجى الإتصال بالأرقام التالية:</strong></p><p dir="RTL"><strong>-</strong><strong> جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة</strong></p><ul><li dir="RTL">الهاتف: 6536666 (12) 966+</li><li dir="RTL">الجوّال: 9882-904-56-966+</li><li dir="RTL">البريد الإلكتروني: gcc.medinfo@gsk.com</li><li dir="RTL">الموقع الإلكتروني: https://gskpro.com/en-sa/</li><li dir="RTL">ص. ب. 55850، جدة 21544، المملكة العربية السعودية</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>للإبلاغ عن أية آثار جانبية</strong><strong>:</strong></p><p dir="RTL"><strong><em>&nbsp;</em></strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- </strong><strong>المركز الوطني للتيقظ والسلامة الدوائية </strong><strong>(</strong><strong>NPC</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاتصال بالرقم الموحد: &nbsp;19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL">- <strong>جلاكسو سميث كلاين &ndash; المقر الرئيسي، جدة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهاتف: &nbsp;+966-12-6536666</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجوال:&nbsp; +966-56-904-9882</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: &nbsp;saudi.safety@gsk.com</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني:&nbsp; https://gskpro.com/en-sa/</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>ص.ب رقم 55850 ، جدة 21544 ، المملكة العربية السعودية.</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم الإصدار14 draft 1: UK Issue 
تاريخ الإصدار: 20 يوليو 2023


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Boostrix suspension for injection in pre-filled syringe 
Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content)

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 dose (0.5 ml) contains:

Diphtheria toxoid1	not less than 2 International Units (IU) (2.5 Lf)
Tetanus toxoid1	not less than 20 International Units (IU) (5 Lf)
Bordetella pertussis antigens
	Pertussis toxoid1	8 micrograms
	Filamentous Haemagglutinin1	8 micrograms
	Pertactin1	2.5 micrograms

1 adsorbed on aluminium hydroxide, hydrated (Al(OH)3)	0.3 milligrams Al3+
and aluminium phosphate (AlPO4)	0.2 milligrams Al3+

The vaccine may contain traces of formaldehyde which is used during the manufacturing process (see section 4.3).

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Suspension for injection in pre-filled syringe.
Boostrix is a turbid white suspension

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Boostrix is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years onwards (see section 4.2).</p><p>&nbsp;</p><p>Boostrix is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy (see sections 4.2, 4.6 and 5.1).</p><p>&nbsp;</p><p>The administration of Boostrix should be based on official recommendations.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><strong>&nbsp;</strong></p><p>A single 0.5 ml dose of the vaccine is recommended.</p><p>&nbsp;</p><p>Boostrix may be administered from the age of four years onwards.</p><p>Boostrix should be administered in accordance with official recommendations and/or local practice regarding the use of vaccines with reduced content of diphtheria, tetanus and pertussis antigens.</p><p>&nbsp;</p><p>Boostrix can be administered to pregnant women during the second or the third trimester in accordance with official recommendations (see sections 4.1, 4.6 and 5.1).</p><p>&nbsp;</p><p>Boostrix may also be administered to adolescents and adults with unknown vaccination status or incomplete vaccination against diphtheria, tetanus and pertussis as part of an immunisation series against diphtheria, tetanus and pertussis. Based on data in adults, two additional doses of a diphtheria and tetanus containing vaccine are recommended one and six months after the first dose to maximize the vaccine response against diphtheria and tetanus (see section 5.1).</p><p>&nbsp;</p><p>Boostrix can be used in the management of tetanus prone injuries in persons who have previously received a primary vaccination series of tetanus toxoid vaccine and for whom a booster against diphtheria and pertussis is indicated. Tetanus immunoglobulin should be administered concomitantly in accordance with official recommendations.</p><p>&nbsp;</p><p>Repeat vaccination against diphtheria, tetanus and pertussis should be performed at intervals as per official recommendations (generally 10 years).</p><p><strong>&nbsp;</strong></p><p><em>Paediatric population</em></p><p>&nbsp;</p><p>The safety and efficacy of Boostrix in children below 4 years of age have not been established.</p><p><strong>&nbsp;</strong></p><p><u>Method of administration</u></p><p>&nbsp;</p><p>Boostrix is for deep intramuscular injection preferably in the deltoid region (see section 4.4).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances or to any of the excipients listed in section 6.1or formaldehyde.

Hypersensitivity after previous administration of diphtheria, tetanus or pertussis vaccines.

Boostrix is contraindicated if the subject has experienced an encephalopathy of unknown aetiology, occurring within 7 days following previous vaccination with pertussis-containing vaccine. In these circumstances, pertussis vaccination should be discontinued and the vaccination course should be continued with diphtheria and tetanus vaccines.

Boostrix should not be administered to subjects who have experienced transient thrombocytopenia or neurological complications (for convulsions or hypotonic-hyporesponsive episodes, see section 4.4) following an earlier immunisation against diphtheria and/or tetanus.

As with other vaccines, administration of Boostrix should be postponed in subjects suffering from acute severe febrile illness. The presence of a minor infection is not a contraindication.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vaccination should be preceded by a review of the medical history (especially with regard to previous vaccination and possible occurrence of undesirable events).</p><p>&nbsp;</p><p>If any of the following events are known to have occurred in temporal relation to receipt of pertussis-containing vaccine, the decision to give doses of pertussis-containing vaccines should be carefully considered:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Temperature of &sup3; 40.0&deg;C within 48 hours of vaccination, not due to another identifiable cause.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Collapse or shock-like state (hypotonic-hyporesponsiveness episode) within 48 hours of vaccination.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Persistent, inconsolable crying lasting &sup3; 3 hours, occurring within 48 hours of vaccination.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Convulsions with or without fever, occurring within 3 days of vaccination.</p><p>There may be circumstances, such as a high incidence of pertussis, when the potential benefits outweigh possible risks.</p><p><strong>&nbsp;</strong></p><p>As for any vaccination, the risk-benefit of immunising with Boostrix or deferring this vaccination should be weighed carefully in a child suffering from a new onset or progression of a severe neurological disorder.</p><p>&nbsp;</p><p>As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic reaction following the administration of the vaccine.</p><p><strong>&nbsp;</strong></p><p>Boostrix should be administered with caution to subjects with thrombocytopenia (see section 4.3) or a bleeding disorder since bleeding may occur following an intramuscular administration to these subjects. If in accordance with official recommendations, the vaccine may be administered subcutaneously to these subjects. With both routes of administration, firm pressure should be applied to the injection site (without rubbing) for at least two minutes.</p><p><strong>&nbsp;</strong></p><p>Boostrix should in no circumstances be administered intravascularly.</p><p><strong>&nbsp;</strong></p><p>A history or a family history of convulsions and a family history of an adverse event following DTP vaccination do not constitute contraindications.</p><p>&nbsp;</p><p>Human Immunodeficiency Virus (HIV) infection is not considered as a contraindication. The expected immunological response may not be obtained after vaccination of immunosuppressed patients.</p><p>&nbsp;</p><p>Syncope (fainting) can occur following, or even before, any vaccination especially in adolescents as a psychogenic response to the needle injection.&nbsp; This can be accompanied by several neurological signs such as transient visual disturbance, paraesthesia and tonic-clonic limb movements during recovery.&nbsp; It is important that procedures are in place to avoid injury from faints.</p><p>&nbsp;</p><p>As with any vaccine, a protective immune response may not be elicited in all vaccinees.</p><p>&nbsp;</p><p><em><u>Excipients</u></em></p><p><em>&nbsp;</em></p><p>This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially &lsquo;sodium‑free&rsquo;.</p><p><strong>&nbsp;</strong></p><p><em><u>Traceability</u></em></p><p>&nbsp;</p><p>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Use with other vaccines or immunoglobulins</strong></p><p>&nbsp;</p><p>Boostrix may be administered concomitantly with human papilloma virus vaccine with no clinically relevant interference with antibody response to any of the components of either vaccine.</p><p>&nbsp;</p><p>Boostrix can be given concomitantly with meningococcal serogroups A, C, W-135 and Y (MenACWY) conjugate vaccines. Clinical studies in subjects aged 9 to 25 years demonstrated that the immune responses to the tetanus, diphtheria and meningococcal antigens were unaffected. Lower geometric mean concentrations (GMCs) were observed for the pertussis antigens; however, these data do not suggest clinically relevant interference.</p><p>&nbsp;</p><p>Boostrix can be given concomitantly with unadjuvanted inactivated seasonal influenza vaccines. When Boostrix was co-administered with a trivalent inactivated influenza vaccine in subjects aged between 19 and 64 years, clinical data demonstrated that the immune responses to the tetanus, diphtheria, pertussis toxoid (PT) and influenza antigens were unaffected. Lower GMCs were observed for the pertussis filamentous haemagglutinin (FHA) and pertactin (PRN) antigens; however, these data do not suggest clinically relevant interference. No differences were observed in a predefined exploratory cohort when the vaccines were given concomitantly or separately to subjects aged 65 years and older.</p><p>&nbsp;</p><p>Boostrix can be given concomitantly with non-live herpes zoster vaccine. Clinical data in subjects aged 50 years and older demonstrated that the immune responses to the tetanus, diphtheria, PT, FHA and herpes zoster antigens were unaffected. Lower GMCs were observed for the PRN antigen; however, these data do not suggest clinically relevant interference.</p><p>&nbsp;</p><p>Concomitant administration of Boostrix<strong> </strong>with other vaccines or with immunoglobulins has not been studied.</p><p>It is unlikely that co-administration with other inactivated vaccines or with immunoglobulins will result in clinically relevant interference with the immune responses.</p><p>&nbsp;</p><p>According to generally accepted vaccine practices and recommendations, if concomitant administration of Boostrix with other vaccines or immunoglobulins is considered necessary, the products should be given at separate sites.</p><p><em>&nbsp;</em></p><p><strong>Use with immunosuppressive treatment</strong></p><p><strong>&nbsp;</strong></p><p>As with other vaccines, patients receiving immunosuppressive therapy may not achieve an adequate response.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>&nbsp;</p><p>Boostrix can be used during the second or third trimester of pregnancy in accordance with official recommendations.</p><p>&nbsp;</p><p>For data relating to the prevention of pertussis disease in infants born to women vaccinated during pregnancy, see section 5.1.</p><p>&nbsp;</p><p>Safety data from a randomised controlled clinical trial (341 pregnancy outcomes) and from a prospective observational study (793 pregnancy outcomes), where Boostrix was administered to pregnant women during the third trimester, have shown no vaccine related adverse effect on pregnancy or on the health of the foetus/newborn child.</p><p>&nbsp;</p><p>Safety data from prospective clinical studies on the use of Boostrix or Boostrix-IPV during the first and second trimester of pregnancy are not available.</p><p>&nbsp;</p><p>Data from passive surveillance where pregnant women were exposed to Boostrix or to Boostrix-IPV (dTpa-IPV vaccine) in the 3rd or 2nd trimester have shown no vaccine-related adverse effect on pregnancy or on the health of the foetus/newborn child.</p><p>&nbsp;</p><p>As with other inactivated vaccines, it is not expected that vaccination with Boostrix harms the foetus at any trimester of pregnancy.</p><p>&nbsp;</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or post-natal development (see section 5.3).</p><p>&nbsp;</p><p><strong>Breastfeeding</strong></p><p>&nbsp;</p><p>The effect of administration of Boostrix during lactation has not been assessed. Nevertheless, as Boostrix contains toxoids or inactivated antigens, no risk to the breastfed infant should be expected. The benefits versus the risk of administering Boostrix to breastfeeding women should carefully be evaluated by the healthcare providers.</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>&nbsp;</p><p>No human data from prospective clinical studies are available.&nbsp; Animal studies do not indicate direct or indirect harmful effects with respect to female fertility (see section 5.3).</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The vaccine is unlikely to produce an effect on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Summary of the safety profile</em></strong></p><p>&nbsp;</p><p>The safety profile presented below is based on data from clinical trials where Boostrix was administered to 839 children (from 4 to 8 years of age) and 1931 adults, adolescents and children (from 10 to 76 years of age) (Table 1).</p><p>&nbsp;</p><p>The most common events occurring after Boostrix administration in both groups were local injection site reactions (pain, redness and swelling) reported by 23.7 &ndash; 80.6% of subjects in each trial. These usually had their onset within the first 48 hours after vaccination. All resolved without sequelae.</p><p>&nbsp;</p><p><strong><em>Tabulated list of adverse reactions</em></strong></p><p>&nbsp;</p><p>Adverse reactions reported are listed according to the following frequency:</p><p>&nbsp;</p><p>Very common:&nbsp; (&sup3;1/10)</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&sup3; 1/100 to &lt; 1/10)</p><p>Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&sup3; 1/1,000 to &lt; 1/100)</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&sup3; 1/10,000 to &lt; 1/1,000)</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&lt; 1/10,000)</p><p><strong><u>&nbsp;</u></strong></p><p>Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Clinical trials</strong></p><p><strong><u>&nbsp;</u></strong></p><p><strong>Table 1: </strong>Adverse reactions reported in clinical trials with Boostrix</p><table border="1" cellspacing="0" cellpadding="0" style="width:612px"><tbody><tr><td rowspan="2"><p><strong><em>System Organ Class</em></strong></p></td><td rowspan="2"><p><strong><em>Frequency</em></strong></p></td><td colspan="2"><p><strong><em>Adverse reactions</em></strong></p></td></tr><tr><td><p><strong><em>Subjects aged 4 - 8 years </em></strong></p><p><strong><em>(N=839)</em></strong></p></td><td><p><strong><em>Subjects aged 10 - 76 years </em></strong></p><p><strong><em>(N = 1931)</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Infections and infestations </em></strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>upper respiratory tract infection</p></td><td style="vertical-align:top"><p>upper respiratory tract infection, pharyngitis</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Blood and lymphatic system disorders</em></strong></p></td><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>lymphadenopathy</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Metabolism and nutrition disorders</em></strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>anorexia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Psychiatric disorders</em></strong></p><p><strong><em>&nbsp;</em></strong></p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>irritability</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong><em>Nervous system disorders</em></strong></p><p><strong><em>&nbsp;</em></strong></p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>somnolence</p></td><td style="vertical-align:top"><p>headache</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>headache</p></td><td style="vertical-align:top"><p>dizziness</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>disturbances in attention</p></td><td style="vertical-align:top"><p>syncope</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Eye disorders</em></strong></p><p><strong><em>&nbsp;</em></strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>conjunctivitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Respiratory, thoracic and mediastinal disorders</em></strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>cough</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Gastrointestinal disorders</em></strong></p><p><strong><em>&nbsp;</em></strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>diarrhoea, vomiting, gastrointestinal disorders</p></td><td style="vertical-align:top"><p>nausea, gastrointestinal disorders</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>diarrhoea, vomiting</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Skin and subcutaneous tissue disorders</em></strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>rash</p></td><td style="vertical-align:top"><p>hyperhidrosis, pruritus, rash</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Musculoskeletal and connective tissue disorders</em></strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>arthralgia, myalgia, joint stiffness, musculoskeletal stiffness</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong><em>General disorders and administration site conditions</em></strong></p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>injection site reactions (such as redness and/or swelling), injection site pain, fatigue</p></td><td style="vertical-align:top"><p>injection site reactions (such as redness and/or swelling), malaise, fatigue, injection site pain</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>pyrexia (fever &ge; 37.5&deg;C including fever &gt; 39.0&deg;C), extensive swelling of vaccinated limb (sometimes involving the adjacent joint)</p></td><td style="vertical-align:top"><p>pyrexia (fever &sup3; 37.5&deg;C), injection site reactions (such as injection site mass and injection site abscess sterile)</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>other injection site reactions (such as induration), pain</p></td><td style="vertical-align:top"><p>pyrexia (fever &gt; 39.0&deg;C), influenza like illness, pain</p></td></tr></tbody></table><p>&nbsp;</p><p><em>Reactogenicity after repeat dose</em></p><p>&nbsp;</p><p>Data on 146 subjects suggest that there might be a small increase in local reactogenicity (pain, redness, swelling) with repeated vaccination according to a 0, 1, 6 months schedule in adults (&gt;&nbsp;40 years of age).</p><p>&nbsp;</p><p>Data suggest that in subjects primed with DTP in childhood a second booster dose might give an increase of local reactogenicity.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Post-marketing surveillance</strong></p><p>&nbsp;</p><p>Because these events were reported spontaneously, it is not possible to reliably estimate their frequency.</p><p><u>&nbsp;</u></p><p><strong><u>Table 2:</u></strong><strong><u> </u></strong><u>Adverse reactions reported with Boostrix during post-marketing surveillance</u></p><table border="1" cellspacing="0" cellpadding="0" style="width:612px"><tbody><tr><td><p><strong><em>System Organ Class</em></strong></p></td><td><p><strong><em>Frequency</em></strong></p></td><td><p><strong><em>Adverse reactions</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Immune system disorders</em></strong></p></td><td style="vertical-align:top"><p>unknown</p></td><td style="vertical-align:top"><p>allergic reactions, including anaphylactic and anaphylactoid reactions</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Nervous system disorders</em></strong></p></td><td style="vertical-align:top"><p>unknown</p></td><td style="vertical-align:top"><p>hypotonic-hyporesponsiveness episodes, convulsions (with or without fever)</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Skin and subcutaneous tissue disorders</em></strong></p></td><td style="vertical-align:top"><p>unknown</p></td><td style="vertical-align:top"><p>urticaria, angioedema</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>General disorders and administration site conditions</em></strong></p></td><td style="vertical-align:top"><p>unknown</p></td><td style="vertical-align:top"><p>asthenia</p></td></tr></tbody></table><p><u>&nbsp;</u></p><p>Following administration of tetanus toxoid containing vaccines, there have been very rare reports of adverse reactions on the central or peripheral nervous systems, including ascending paralysis or even respiratory paralysis (e.g. Guillain-Barr&eacute; syndrome).</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting Hotline: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p><u>&nbsp;</u></p><p><strong>- GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: saudi.safety@gsk.com<u>&nbsp; </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/<u> </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cases of overdose have been reported during post-marketing surveillance. Adverse events following overdosage, when reported, were similar to those reported with normal vaccine administration.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5.1&nbsp;&nbsp;&nbsp; Pharmacodynamic properties<!--[if supportFields]><span lang=EN-GB style='font-size:12.0pt;
mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi'><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d49d9051-a828-4fb8-a32b-af2b3d920c64 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
lang=EN-GB style='font-size:12.0pt;mso-ascii-font-family:"Times New Roman";
mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi'><span style='mso-element:field-end'></span></span><![endif]--></p><p><s>&nbsp;</s></p><p>Pharmacotherapeutic group: Bacterial vaccines, pertussis vaccines, ATC code: J07AJ52</p><p>&nbsp;</p><p><em>Immune response</em></p><p><em>&nbsp;</em></p><p>Approximately one month following booster vaccination with Boostrix, the following seroprotection / seropositivity rates were observed (Table 3).</p><p><strong>Table 3</strong>: Immune response in children, adolescents and adults</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Antigen</strong></p></td><td><p><strong>Response<sup>(1)</sup></strong></p></td><td><p><strong>Adults and adolescents from the age of 10 years onwards</strong></p><p><strong>ATP<sup>(2)</sup></strong></p><p><strong>N=1694</strong></p><p>(% vaccinees)</p></td><td><p><strong>Children from the age of 4 years onwards</strong></p><p><strong>ATP<sup>(2)</sup></strong></p><p><strong>N=415</strong></p><p>(% vaccinees)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Diphtheria</strong></p></td><td style="vertical-align:top"><p>&sup3; 0.1 IU/ml</p></td><td style="vertical-align:top"><p>97.2%</p></td><td style="vertical-align:top"><p>99.8%</p></td></tr><tr><td style="vertical-align:top"><p><strong>Tetanus</strong></p></td><td style="vertical-align:top"><p>&sup3; 0.1 IU/ml</p></td><td style="vertical-align:top"><p>99.0%</p></td><td style="vertical-align:top"><p>100.0%</p></td></tr><tr><td style="vertical-align:top"><p><strong>Pertussis:</strong></p><p>- Pertussis toxoid</p><p>- Filamentous haemagglutinin</p><p>- Pertactin</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&sup3; 5 EL.U/ml</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>97.8%</p><p>99.9%</p><p>99.4%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>99.0%</p><p>100.0%</p><p>99.8%</p></td></tr></tbody></table><p><sup>(1)</sup>Response: where, at the specified time point, a concentration of antibodies against diphtheria and tetanus &sup3; 0.1 IU/ml was considered as seroprotection and a concentration of antibodies against pertussis &sup3; 5 EL.U/ml was considered as seropositivity.</p><p><sup>(2)</sup>ATP: According to protocol &ndash; includes all eligible subjects, who had received a single booster dose of Boostrix, for whom immunogenicity data was available for at least one antigen at the specified time-point.</p><p>N: the minimum number of subjects with available data for each antigen</p><p>&nbsp;</p><p>In adolescents and adults, comparative trials have demonstrated that one month post-vaccination, diphtheria antibody titres are similar to adult-type Td vaccines with the same antigen content as Boostrix; lower tetanus antibody titres were seen as compared to adult-type Td vaccines.</p><p>&nbsp;</p><p>As with other adult-type Td vaccines, Boostrix induces higher titres of both anti-D and anti-T antibodies in children and adolescents as compared to adults.</p><p>&nbsp;</p><p><em>Persistence of the immune response</em></p><p>&nbsp;</p><p>Three to 3.5 years, 5 to 6 years and 10 years following a first vaccination with Boostrix, the following seroprotection/seropositivity rates were observed in subjects vaccinated according to protocol (ATP<sup>1</sup>) (Table 4).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" align="left" style="width:716px"><tbody><tr><td rowspan="2" style="vertical-align:top"><p><strong>Antigen</strong></p></td><td rowspan="2" style="vertical-align:top"><p><strong>&nbsp;Response<sup>(2)</sup></strong></p></td><td colspan="6"><p><strong>Adults and adolescents from the age of 10 years onwards</strong></p><p><strong>(% vaccinees)</strong></p></td><td colspan="2"><p><strong>Children from the age of 4 years onwards</strong></p><p><strong>(% vaccinees)</strong></p></td></tr><tr><td colspan="2"><p>3-3.5 years persistence</p></td><td colspan="2"><p>5 years persistence</p></td><td colspan="2"><p>10 years persistence</p></td><td><p>3-3.5 years persistence</p></td><td><p>5 to 6 years persistence</p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td><p>Adult<sup>(3)</sup></p><p>(N=309)</p></td><td><p>Adole-scent<sup>(3)</sup></p><p>(N=261)</p></td><td><p>Adult<sup>(3)</sup></p><p>(N=232)</p></td><td><p>Adole-scent<sup>(3)</sup> (N=250)</p></td><td><p>Adult<sup>(3)</sup></p><p>(N=158)</p></td><td><p>Adole-scent<sup>(3)</sup> (N=74)</p></td><td><p>(N=118)</p></td><td><p>(N=68)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Diphtheria</strong></p></td><td style="vertical-align:top"><p>&sup3; 0.1 IU/ml</p></td><td><p>71.2%</p></td><td><p>91.6%</p></td><td><p>84.1%</p></td><td><p>86.8%</p></td><td><p>64.6%</p></td><td><p>82.4%</p></td><td><p>97.5 %</p></td><td><p>94.2 %</p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td><p>&sup3; 0.016 IU/ml<sup>(4)</sup></p></td><td><p>97.4%</p></td><td><p>100%</p></td><td><p>94.4%</p></td><td><p>99.2%</p></td><td><p>89.9%</p></td><td><p>98.6%</p></td><td><p>100 %</p></td><td><p>Not determined</p></td></tr><tr><td><p><strong>Tetanus</strong></p></td><td><p>&sup3; 0.1 IU/ml</p></td><td><p>94.8%</p></td><td><p>100%</p></td><td><p>96.2%</p></td><td><p>100%</p></td><td><p>95.0%</p></td><td><p>97.3%</p></td><td><p>98.4 %</p></td><td><p>98.5 %</p></td></tr><tr><td style="vertical-align:top"><p><strong>Pertussis</strong></p><p>Pertussis toxoid</p><p>Filamentous</p><p>haemagglutinin</p><p>&nbsp;Pertactin</p></td><td><p>&sup3; 5 EL.U/ml</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>90.6%</p><p>&nbsp;</p><p>100%</p><p>94.8%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>81.6%</p><p>&nbsp;</p><p>100%</p><p>99.2%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>89.5%</p><p>&nbsp;</p><p>100%</p><p>95.0%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>76.8%</p><p>&nbsp;</p><p>100%</p><p>98.1%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>85.6%</p><p>&nbsp;</p><p>99.4%</p><p>95.0%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>61.3%</p><p>&nbsp;</p><p>100%</p><p>96.0%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>58.7 %</p><p>&nbsp;</p><p>100 %</p><p>99.2 %</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>51.5 %</p><p>&nbsp;</p><p>100 %</p><p>100 %</p></td></tr></tbody></table><p><strong>Table 4</strong>: Persistence of immune response in children, adolescents and adults</p><p><sup>(1)</sup>ATP: According to protocol &ndash; includes all eligible subjects, who had received a single booster dose of Boostrix, for whom immunogenicity data was available for at least one antigen at the specified time-point.</p><p><sup>(2)</sup>Response: Where, at the specified time point, a concentration of antibodies against diphtheria and tetanus &sup3; 0.1 IU/ml was considered as seroprotection and a concentration of antibodies against pertussis &sup3; 5 EL.U/ml was considered as seropositivity.</p><p><sup>(3)</sup>The terms &lsquo;adult&rsquo; and &lsquo;adolescent&rsquo; reflect the ages at which subjects received their first vaccination with Boostrix.</p><p><sup>(4)</sup>Percentage of subjects with antibody concentrations associated with protection against disease (&sup3; 0.1 IU/ml by ELISA assay or &sup3; 0.016 IU/ml by an in-vitro Vero-cell neutralisation assay).</p><p>N = the minimum number of subjects with available data for each antigen</p><p>&nbsp;</p><p><em>Efficacy in protecting against pertussis</em></p><p>&nbsp;</p><p>The pertussis antigens contained in Boostrix are an integral part of the paediatric acellular pertussis combination vaccine (Infanrix), for which efficacy after primary vaccination has been demonstrated in a household contact efficacy study. The antibody titres to all three pertussis components following vaccination with Boostrix are higher than those observed during the household contact efficacy trial. Based on these comparisons, Boostrix would provide protection against pertussis, however the degree and duration of protection afforded by the vaccine are undetermined.</p><p>&nbsp;</p><p><em>Passive protection against pertussis in infants (below 3 months of age) born to mothers vaccinated during pregnancy</em></p><p>&nbsp;</p><p>In a randomised, cross-over, placebo-controlled study, higher pertussis antibody concentrations were demonstrated at delivery in the cord blood of babies born to mothers vaccinated with Boostrix (dTpa group; N=291) versus placebo (control group; N=292) at 27-36 weeks of pregnancy. The cord blood geometric mean concentrations of antibodies against the pertussis antigens PT, FHA and PRN were 46.9, 366.1 and 301.8 IU/ml in the dTpa group, and 5.5, 22.7 and 14.6 IU/ml in the control group. This corresponds to antibody titres that are 8, 16 and 21 times higher in the cord blood of babies born to vaccinated mothers versus controls. These antibody titres may provide passive protection against pertussis as shown by observational effectiveness studies.</p><p>&nbsp;</p><p>Immunogenicity in infants and toddlers born to mothers vaccinated during pregnancy</p><p>&nbsp;</p><p>The immunogenicity of Infanrix hexa (diphtheria, tetanus, pertussis, hepatitis B, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccine) in infants and toddlers born to healthy mothers vaccinated with Boostrix at 27-36 weeks of pregnancy was evaluated in two clinical studies.</p><p>Infanrix hexa was co-administered with a 13-valent pneumococcal conjugate vaccine to infants for primary vaccination (n=268); and to the same infants/toddlers from 11 to 18 months as booster dose (n=229).</p><p>&nbsp;</p><p>Post-primary and post-booster vaccination, immunological data did not show clinically relevant interference of maternal vaccination with Boostrix on the infant&rsquo;s and toddler&rsquo;s responses to diphtheria, tetanus, hepatitis B, inactivated poliovirus, Haemophilus influenzae type b or pneumococcal antigens.</p><p>&nbsp;</p><p>Lower antibody concentrations against pertussis antigens post-primary (PT, FHA and PRN) and post-booster (PT, FHA) vaccination were observed in infants and toddlers born to mothers vaccinated with Boostrix during pregnancy. The fold-increases of anti-pertussis antibody concentrations from the pre-booster to the 1-month post-booster time point were in the same range for infants and toddlers born to mothers vaccinated with Boostrix or with placebo, demonstrating effective priming of the immune system. In the absence of correlates of protection for pertussis, the clinical relevance of these observations remains to be fully understood. However, current epidemiological data on pertussis disease following the implementation of dTpa maternal immunisation do not suggest any clinical relevance of this immune interference.</p><p>&nbsp;</p><p><em>Effectiveness in the protection against pertussis disease in infants born to women vaccinated during pregnancy</em></p><p><em>&nbsp;</em></p><p>Boostrix or Boostrix-IPV vaccine effectiveness (VE) was evaluated in three observational studies, in UK, Spain and Australia. The vaccine was used during the third trimester of pregnancy to protect infants below 3 months of age against pertussis disease, as part of a maternal vaccination programme.</p><p>&nbsp;</p><p>Details of each study design and results are provided in Table 5.</p><p>Table 5: VE against pertussis disease for infants below 3 months of age born to mothers vaccinated during the third trimester of pregnancy with Boostrix/Boostrix-IPV:</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Study location</strong></p></td><td style="vertical-align:top"><p><strong>Vaccine</strong></p></td><td style="vertical-align:top"><p><strong>Study design</strong></p></td><td style="vertical-align:top"><p><strong>Vaccination Effectiveness</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>UK</strong></p></td><td style="vertical-align:top"><p>Boostrix-IPV</p></td><td style="vertical-align:top"><p>Retrospective, screening method</p></td><td style="vertical-align:top"><p>88% (95% CI: 79, 93)</p><p><em>&nbsp;</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Spain</strong></p></td><td style="vertical-align:top"><p>Boostrix</p></td><td style="vertical-align:top"><p>Prospective, matched case-control</p></td><td style="vertical-align:top"><p>90.9% (95% CI: 56.6, 98.1)</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Australia</strong></p></td><td style="vertical-align:top"><p>Boostrix</p></td><td style="vertical-align:top"><p>Prospective, matched case-control</p></td><td style="vertical-align:top"><p>69% (95% CI: 13, 89)</p><p><em>&nbsp;</em></p></td></tr></tbody></table><p>CI: confidence interval</p><p>&nbsp;</p><p>If maternal vaccination occurs within two weeks before delivery, vaccine effectiveness in the infant may be lower than the figures in the table.</p><p>&nbsp;</p><p><em>Immune response after a repeat dose of Boostrix</em></p><p>&nbsp;</p><p>The immunogenicity of Boostrix, administered 10 years after a previous booster dose with reduced-antigen content diphtheria, tetanus and acellular pertussis vaccine(s) has been evaluated. One month post vaccination, &gt; 99 % of subjects were seroprotected against diphtheria and tetanus and seropositive against pertussis.</p><p>&nbsp;</p><p><em>Immune response in subjects without prior or with unknown vaccination history</em></p><p>&nbsp;</p><p>After administration of one dose of Boostrix to 83 adolescents aged from 11 to 18 years, without previous pertussis vaccination and no vaccination against diphtheria and tetanus in the previous 5 years, all subjects were seroprotected against tetanus and diphtheria. The seropositivity rate after one dose varied between 87% and 100% for the different pertussis antigens.</p><p>&nbsp;</p><p>After administration of one dose of Boostrix to 139 adults &sup3; 40 years of age that had not received any diphtheria and tetanus containing vaccine in the past 20 years, more than 98.5% of adults were seropositive for all three pertussis antigens and 81.5% and 93.4% were seroprotected against diphtheria and tetanus respectively. After administration of two additional doses one and six months after the first dose, the seropositivity rate was 100% for all three pertussis antigens and the seroprotection rates for diphtheria and tetanus reached 99.3% and 100% respectively.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Evaluation of pharmacokinetic properties is not required for vaccines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Reproductive toxicology</strong></p><p><strong>&nbsp;</strong></p><p><em>Fertility</em></p><p>&nbsp;</p><p>Non-clinical data obtained with Boostrix reveal no specific hazard for humans based on conventional studies of female fertility in rats and rabbits.</p><p>&nbsp;</p><p><em>Pregnancy</em></p><p>&nbsp;</p><p>Non-clinical data obtained with Boostrix reveal no specific hazard for humans based on conventional studies of embryo-foetal development in rats and rabbits, and also of parturition and postnatal toxicity in rats (up to the end of the lactation period).</p><p>&nbsp;</p><p><strong>Animal toxicology and/or pharmacology</strong></p><p>&nbsp;</p><p>Preclinical data reveal no special hazard for humans based on conventional studies of safety and of toxicity.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride</p><p>Water for injections</p><p>&nbsp;</p><p>For adjuvants, see section 2.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&deg;C &ndash; 8&deg;C).</p><p>&nbsp;</p><p>Stability data indicate that Boostrix is stable at temperatures up to 37&deg;C. for 7 days. At the end of this period. Boostrix should be used or discarded. These data are intended to guide healthcare professionals in case of temporary temperature excursion only.</p><p>&nbsp;</p><p><strong>Do not freeze. </strong></p><p>&nbsp;</p><p>Store in the original package in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>0.5 ml of suspension in a pre-filled syringe (type I glass) with a plunger stopper (butyl rubber) and with a rubber tip cap. Pack sizes of 1 and 10, with or without needles.</p><p>&nbsp;</p><p>The tip cap and the rubber plunger stopper of the pre-filled syringe are made with synthetic rubber.</p><p>&nbsp;</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prior to use, the vaccine should be at room temperature, and well shaken in order to obtain a homogeneous turbid white suspension.<strong> </strong>Prior to administration, the vaccine should be<strong><em> </em></strong>visually inspected for any foreign particulate matter and/or variation of physical aspect. In the event of either being observed, do not administer the vaccine.</p><p><strong>&nbsp;</strong></p><p><img src="data:image/png;base64,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" alt="" width="300" height="229" vspace="0" hspace="0" border="0" style="width:300px;height:229px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p><strong><u>Disposal</u></strong><strong>:</strong></p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p><strong>Boostrix is a trademark owned by or GSK group of companies. </strong></p><p><strong>&copy;2023 GSK, all rights reserved.</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>Website: https://gskpro.com/en-sa/<u> </u></li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufacturer: 
GlaxoSmithKline Biologicals, s.a.
89, rue de l’Institut - 1330 Rixensart
Belgium
Tel: (32) 2 656 81 11     Fax: (32) 2 656 80 00

Marketing Authorization Holder: 
Glaxo Saudi Arabia Ltd.* Jeddah, KSA.
Address: P.O. Box 22617 Jeddah 21416 – Kingdom of Saudi Arabia.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: UK Issue 24 draft 1 / Date of issue: 20 July 2023 
ã [2023] GSK group of companies 

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>